ArticleProceedings of the National Academy of Sciences of the United States of America2014

Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels.

Ming-Kang Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.